Thiago Gava Nogueira

I lead the largest and most strategic district in Brazil, composed of 11 consultants specialized in CNS, covering São Paulo Capital, Guarulhos, Santana de Parnaíba, Barueri, Cotia, and Osasco. I manage the territory as a business unit, integrating commercial strategy, Market Access, and Business Intelligence (IQVIA, Close-Up, Qlik, Salesforce) to drive consistent growth in highly complex markets. Key Responsibilities: • Commercial Strategy & Market Intelligence Development of data-driven territorial plans with advanced medical segmentation, dynamic targeting, and strategic routing, resulting in +15% qualified coverage. • Leadership & Team Development Implementation of structured coaching, management rituals, advanced use of KPIs and BI dashboards, building highly autonomous and accountable teams that consistently exceed performance targets. • Commercial Execution & Strategic Launches Management of innovative CNS molecule launches (next-generation antipsychotics, multimodal antidepressants), ensuring accelerated penetration and tactical execution aligned with competitive dynamics. • Market Access & Institutional Stakeholders Negotiation with C-level executives, hospital managers, and public/private decision-makers to unlock access, expand institutional presence, and strengthen the scientific positioning of the portfolio. • Cross-Functional Integration Leadership of initiatives with Marketing, Medical Affairs, and KAM to optimize promotional strategy, portfolio profitability, and impact within the healthcare ecosystem. • Performance Management & Commercial Predictability Monitoring of KPIs, forecasts, territorial productivity, and commercial ROI, structuring tactical plans that achieved target overperformance of up to 20%. • Regulatory Access & Advocacy Participation in regulatory discussions (CONITEC, ANS, ISPOR) and patient journey strategies, enhancing sustainable access in high-complexity diseases.

• Atuação consultiva especializada em SNC com forte base científica e engajamento com prescritores especialistas em neurologia e psiquiatria. • Desenvolvimento de relacionamento com líderes de opinião, comunicando evidências científicas e valor terapêutico do portfólio. • Construção da base relacional e de inteligência de mercado que sustentou a transição para a gestão do distrito mais estratégico da companhia no Brasil. • Participação em iniciativas de acesso ao mercado e engajamento institucional junto a hospitais e gestores em São Paulo.

Leadership of a district covering 16 cities, including São Paulo Capital, Guarulhos, Greater ABC, Baixada Santista, Vale do Paraíba, Osasco, and Alphaville. Focused on sustainable growth, territorial expansion, and consolidation of institutional presence in highly competitive markets. • Leadership of 9 specialist representatives in a complex territory. • Data-driven commercial strategy, sustaining an average annual growth of 10%. • Territorial expansion with +15% qualified coverage in previously unvisited regions. • Cross-functional collaboration with Marketing and Medical Affairs, maximizing promotional ROI. • Performance management through KPIs, forecasting, and institutional account oversight, strengthening presence in strategic healthcare services.

Consistent evolution of scope and influence in promoting the CNS portfolio, with a consultative approach, strong technical-scientific foundation, and recurrent use of market data to drive decision-making in highly competitive territories. Key Deliverables: • Strategic promotion of the CNS portfolio, with emphasis on launching the Brand Generics portfolio in Brazil, progressing from developing territories to mature, high-potential markets. • Development of a network of KOLs and therapeutic influencers, strengthening the company’s institutional positioning within targeted specialties. • Continuous analysis of market data, audits, and medical panels, guiding strategic adjustments and territorial prioritization. • Implementation of a consultative approach and personalized messaging, expanding territorial penetration, qualified coverage, and prescribing consistency. • Coordination of scientific events and symposia, consolidating institutional image and brand recognition. • Consistent overachievement of targets, with cumulative growth exceeding 60% during the period. • Role as a technical reference within the territory and informal mentoring of new representatives, disseminating best practices and scientific-commercial rigor.

• Promotion of a portfolio focused on cardiology and respiratory therapies, with a structured approach and generation of qualified demand. • Building relationships with specialist physicians, strengthening the company’s institutional presence and scientific credibility within the territory. • Planning and execution of visits based on territorial analysis and opportunity prioritization. • Consistent achievement of commercial targets, consolidating technical and behavioral foundations for performance in more complex markets.

• Atuação no relançamento estratégico de Enfamil no mercado brasileiro, com foco em reposicionamento de marca e expansão de prescrição junto a pediatras. • Desenvolvimento de território em Belo Horizonte e São Paulo com foco em construção de relacionamento com especialistas e crescimento sustentável de portfólio.

Formative phase of my career in the pharmaceutical industry, with intensive exposure to medical education, market analysis, and portfolio positioning in new markets. • Strategic relaunch of Enfamil, focused on brand repositioning and expanding prescriptions among pediatricians. • Execution of continuing medical education programs, developing strong scientific communication skills and ethical influence. • Market data and audit analysis to monitor territorial performance and guide strategic adjustments. • Development of fundamental skills in negotiation, planning, and relationship-building with healthcare professionals.